![Mark Owens Thornton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Owens Thornton
Nessuna posizione attualmente
Profilo
Mark Owens Thornton worked as a Managing Director-Clinical & Regulatory Affairs at Angiotech Pharmaceuticals, Inc. from 2005 to 2006.
He then worked as a Director at Excel-Tech Ltd.
from 2006 to 2007.
From 2006 to 2010, he was a Senior Vice President-Product Development at GenVec, Inc. Prior to that, he was the Chief Medical Officer at ZIOPHARM, Inc. from 2001 to 2005.
Thornton's education includes a graduate degree from The Johns Hopkins University and a doctorate degree from West Virginia University.
Precedenti posizioni note di Mark Owens Thornton
Società | Posizione | Fine |
---|---|---|
GENVEC INC | Corporate Officer/Principal | 23/05/2010 |
Excel-Tech Ltd.
![]() Excel-Tech Ltd. Medical SpecialtiesHealth Technology Excel-Tech Ltd. engages in the manufacture of musculoskeletal therapy equipment. It designs and produces neuromuscular and neurophysiological instruments. Its IP-enabled medical solutions address the complete spectrum of monitoring and diagnosis of conditions affecting the central and peripheral nervous systems. The company was founded by John Mumford in 1985 and is headquartered in Oakville, Canada. | Direttore/Membro del Consiglio | 30/11/2007 |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
ZIOPHARM, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/2005 |
NOVAVAX, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Mark Owens Thornton
West Virginia University | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Aziende private | 4 |
---|---|
GenVec, Inc.
![]() GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Excel-Tech Ltd.
![]() Excel-Tech Ltd. Medical SpecialtiesHealth Technology Excel-Tech Ltd. engages in the manufacture of musculoskeletal therapy equipment. It designs and produces neuromuscular and neurophysiological instruments. Its IP-enabled medical solutions address the complete spectrum of monitoring and diagnosis of conditions affecting the central and peripheral nervous systems. The company was founded by John Mumford in 1985 and is headquartered in Oakville, Canada. | Health Technology |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
ZIOPHARM, Inc. | Health Technology |
- Borsa valori
- Insiders
- Mark Owens Thornton